What next for Sanofi Dengue vaccine?
This article was originally published in Scrip
Executive Summary
A high stakes effort is underway in Southeast Asia public health policy that brings the expertise of Sanofi Pasteur to a mosquito-borne virus that has been a focus of health ministries as they struggle to work out models to fund both immediate needs and longer-range campaigns.